Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FHIG vs Doxorubicin/Docetaxel in Advanced Gastric Cancer
NCT00003172Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Dec 1997
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of fluorouracil, hydroxyurea, interferon alfa-2a, doxorubicin, docetaxel in gastric cancer (GC), sponsored by Eastern Cooperative Oncology Group. Started Dec 1997; status: completed.
02
Drugs
fluorouracilhydroxyureainterferon alfa-2adoxorubicindocetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00003172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003172.